These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 10848873

  • 1. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
    Jalali R, Brada M, Perks JR, Warrington AP, Traish D, Burchell L, McNair H, Thomas DG, Robinson S, Johnston DG.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 10848873
    [Abstract] [Full Text] [Related]

  • 2. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience.
    Jalali, Brada, Perks, Warrington, Traish, Burchell, McNair, Thomas, Robinson, Johnston.
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):695-702. PubMed ID: 28796354
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas.
    Minniti G, Saran F, Traish D, Soomal R, Sardell S, Gonsalves A, Ashley S, Warrington J, Burke K, Mosleh-Shirazi A, Brada M.
    Radiother Oncol; 2007 Jan; 82(1):90-5. PubMed ID: 17161483
    [Abstract] [Full Text] [Related]

  • 5. High precision conformal radiotherapy employing conservative margins in childhood benign and low-grade brain tumours.
    Jalali R, Budrukkar A, Sarin R, Sharma DS.
    Radiother Oncol; 2005 Jan; 74(1):37-44. PubMed ID: 15683667
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX, Mai WY, Teh BS, Zhao C, Han F, Huang Y, Deng XW, Lu LX, Huang SM, Zeng ZF, Lin CG, Lu HH, Chiu JK, Carpenter LS, Grant WH, Woo SY, Cui NJ, Butler EB.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):682-7. PubMed ID: 14967420
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study.
    Schalin-Jäntti C, Valanne L, Tenhunen M, Setälä K, Paetau A, Sane T, Kouri M.
    Clin Endocrinol (Oxf); 2010 Jul 01; 73(1):72-7. PubMed ID: 20039898
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical outcome in children with recurrent craniopharyngioma after primary surgery.
    Kalapurakal JA, Goldman S, Hsieh YC, Tomita T, Marymont MH.
    Cancer J; 2000 Jul 01; 6(6):388-93. PubMed ID: 11131489
    [Abstract] [Full Text] [Related]

  • 15. High precision focused irradiation in the form of fractionated stereotactic conformal radiotherapy (SCRT) for benign meningiomas predominantly in the skull base location.
    Jalali R, Loughrey C, Baumert B, Perks J, Warrington AP, Traish D, Ashley S, Brada M.
    Clin Oncol (R Coll Radiol); 2002 Apr 01; 14(2):103-9. PubMed ID: 12069116
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Spot-scanning proton radiation therapy for recurrent, residual or untreated intracranial meningiomas.
    Weber DC, Lomax AJ, Rutz HP, Stadelmann O, Egger E, Timmermann B, Pedroni ES, Verwey J, Miralbell R, Goitein G, Swiss Proton Users Group.
    Radiother Oncol; 2004 Jun 01; 71(3):251-8. PubMed ID: 15172139
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment accuracy of fractionated stereotactic radiotherapy.
    Kumar S, Burke K, Nalder C, Jarrett P, Mubata C, A'hern R, Humphreys M, Bidmead M, Brada M.
    Radiother Oncol; 2005 Jan 01; 74(1):53-9. PubMed ID: 15683670
    [Abstract] [Full Text] [Related]

  • 20. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D, Martinez A, Yan D, Lockman D, Wallace M, Gustafson G, Chen P, Vicini F, Wong J.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):400-8. PubMed ID: 15667959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.